Product Name
CAS Number
Specification
TP
DMF
Status
Tofacitinib Citrate
540737-29-9
In-house
√
Tofacitinib Citrate
540737-29-9
In-house
√
Tofogliflozin
1201913-82-7
Q4 2025
Q2 2026
Tovorafenib
1096708-71-2
Q4 2025
Q2 2026
Trametinib dimethyl sulfoxide
1187431-43-1
In-house
Q4 2025
Travoprost
157283-68-6
USP, In-house
√
Tucatinib
937263-43-9
Q3 2025
Q1 2026
Upadacitinib
1310726-60-3
Q3 2025
Q1 2026
Vanzacaftor
2374124-49-7
Q4 2025
Q2 2026
Venetoclax
1257044-40-8
Q3 2025
Q1 2026
Vosoritide
1480724-61-5
Zavegepant
1337918-83-8
Q1 2026
Q3 2026
Ziconotide Acetate
107452-89-1
Sitafloxacin
163253-35-8
Enterprise Standard
√
A
Sodium Glycerophosphate
343306-79-6
Enterprise Standard
√
A
Febuxostat
144060-53-7
Enterprise Standard
√
A
Posaconazole
171228-49-2
Enterprise Standard
√
A
Miglitol
72432-03-2
JP, Enterprise Standard
√
A
Bicyclol
118159-48-1
CP, Enterprise Standard
√
A
Macitentan
441798-33-0
Enterprise Standard
√
A